In order to obtain this action we must pay 28,25$ right now, Immunovant Inc, with address at 320 WEST 37TH STREET 6TH FLOOR, NEW YORK, New York, 10018, United States, is a publicly traded company and its visible heads at the moment are Julia G. Butchko (Chief Development & Technology Officer), Michael Elliott (Chief Scientific Officer), Peter Salzmann (Chief Executive Officer & Director), Sandeep C. Kulkarni (Chief Operating Officer), Tracy Newbold (Vice President-Clinical Operations), William L. Macias (Chief Medical Officer). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
Yesterday this stock ended the day with a value of desconocido$.
With an intraday difference of 28,28$ moving between 27,30$ and 29,26$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The last registered opening is of desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
